精神心理科指南

订阅

MedSci主页 / 所有栏目 / 精神心理科指南

2021 日本专家共识：精神分裂症的药物治疗

2021-01-12 Pharmacopsychiatry . 2021 Jan 12.

精神分裂症

由13名专家组成的JSCNP医学教育专家组确定了19个既往文献未能充分回答的课题，并邀请全部会员参与调研，最终形成了精神分裂症药物治疗专家共识。

中文标题：

2021 日本专家共识：精神分裂症的药物治疗

英文标题：

Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus

发布机构：

发布日期：

2021-01-12

简要介绍：

由13名专家组成的JSCNP医学教育专家组确定了19个既往文献未能充分回答的课题，并邀请全部会员参与调研，最终形成了精神分裂症药物治疗专家共识。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 日本专家共识：精神分裂症的药物治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=95ba21c0020615dd, title=2021 日本专家共识：精神分裂症的药物治疗, enTitle=Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus, guiderFrom=Pharmacopsychiatry . 2021 Jan 12., authorId=0, author=, summary=由13名专家组成的JSCNP医学教育专家组确定了19个既往文献未能充分回答的课题，并邀请全部会员参与调研，最终形成了精神分裂症药物治疗专家共识。, cover=https://img.medsci.cn/2021215/1613319616697_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Jan 12 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>由13名专家组成的JSCNP医学教育专家组确定了19个既往文献未能充分回答的课题，并邀请全部会员参与调研，最终形成了精神分裂症药物治疗专家共识。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1344, tagName=精神分裂症)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1344, guiderKeyword=精神分裂症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12488, appHits=278, showAppHits=0, pcHits=1577, showPcHits=12210, likes=1, shares=13, comments=17, approvalStatus=1, publishedTime=Mon Feb 15 00:20:37 CST 2021, publishedTimeString=2021-01-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Feb 15 00:20:22 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 13:32:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 日本专家共识：精神分裂症的药物治疗.pdf)])
2021 日本专家共识：精神分裂症的药物治疗.pdf
下载请点击：
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1208325, encodeId=0b2b1208325c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Sun Apr 03 10:51:35 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079346, encodeId=d5ea10e9346e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:38:25 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058586, encodeId=6b33105858690, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91735627987, createdName=ms6000000677539406, createdTime=Fri Oct 08 12:55:05 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006922, encodeId=3b8d10069226b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 11 11:43:49 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000669, encodeId=d63b1000669dc, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc815551760, createdName=18薛定谔的猫81, createdTime=Sun Jul 18 20:36:31 CST 2021, time=2021-07-18, status=1, ipAttribution=)]
    2022-04-03 1881eacd07m

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1208325, encodeId=0b2b1208325c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Sun Apr 03 10:51:35 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079346, encodeId=d5ea10e9346e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:38:25 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058586, encodeId=6b33105858690, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91735627987, createdName=ms6000000677539406, createdTime=Fri Oct 08 12:55:05 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006922, encodeId=3b8d10069226b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 11 11:43:49 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000669, encodeId=d63b1000669dc, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc815551760, createdName=18薛定谔的猫81, createdTime=Sun Jul 18 20:36:31 CST 2021, time=2021-07-18, status=1, ipAttribution=)]
    2021-12-12 ms8000001575079939

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1208325, encodeId=0b2b1208325c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Sun Apr 03 10:51:35 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079346, encodeId=d5ea10e9346e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:38:25 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058586, encodeId=6b33105858690, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91735627987, createdName=ms6000000677539406, createdTime=Fri Oct 08 12:55:05 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006922, encodeId=3b8d10069226b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 11 11:43:49 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000669, encodeId=d63b1000669dc, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc815551760, createdName=18薛定谔的猫81, createdTime=Sun Jul 18 20:36:31 CST 2021, time=2021-07-18, status=1, ipAttribution=)]
    2021-10-08 ms6000000677539406

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1208325, encodeId=0b2b1208325c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Sun Apr 03 10:51:35 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079346, encodeId=d5ea10e9346e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:38:25 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058586, encodeId=6b33105858690, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91735627987, createdName=ms6000000677539406, createdTime=Fri Oct 08 12:55:05 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006922, encodeId=3b8d10069226b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 11 11:43:49 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000669, encodeId=d63b1000669dc, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc815551760, createdName=18薛定谔的猫81, createdTime=Sun Jul 18 20:36:31 CST 2021, time=2021-07-18, status=1, ipAttribution=)]
    2021-08-11 ms5000000793547615

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1208325, encodeId=0b2b1208325c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Sun Apr 03 10:51:35 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079346, encodeId=d5ea10e9346e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:38:25 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058586, encodeId=6b33105858690, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91735627987, createdName=ms6000000677539406, createdTime=Fri Oct 08 12:55:05 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006922, encodeId=3b8d10069226b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 11 11:43:49 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000669, encodeId=d63b1000669dc, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc815551760, createdName=18薛定谔的猫81, createdTime=Sun Jul 18 20:36:31 CST 2021, time=2021-07-18, status=1, ipAttribution=)]
    2021-07-18 18薛定谔的猫81

    学习学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2020 APA实践指南：精神分裂症的治疗（第3版）

美国精神病学会(APA,American Psychiatric Association) · 2020-09-01

精神分裂症患者代谢综合征管理的中国专家共识

中华医学会精神病学分会 · 2020-01-30

2019 BAP循证指南：精神分裂症的药物治疗（更新版）

英国精神药理协会(BAP,British Association for Psychopharmacology) · 2019-12-12

2016NICE：儿童和青少年精神病和精神分裂症:识别和管理指南更新

暂未更新 · 2016-06-12

2016 RANZCP临床实践指南：精神分裂症及其相关疾病的管理

澳大利亚与新西兰皇家精神科医师学会(RANZCP,Royal Australian and New Zealand college of Psychiatrists) · 2016-04-27

WFSBP 精神分裂症的生物学治疗指南，第2部分：精神分裂症的长期治疗和抗精神病药物副作用的管理（2012年更新）

世界生物精神病学会联合会(WFSBP,World Federation of Societies of Biological Psychiatry) · 2012-12-06

拓展阅读

WFSBP 精神分裂症的生物学治疗指南，第2部分：精神分裂症的长期治疗和抗精神病药物副作用的管理（2012年更新）

世界生物精神病学会联合会(WFSBP,World Federation of Societies of Biological Psychiatry) · 2012-12-06

2016 RANZCP临床实践指南：精神分裂症及其相关疾病的管理

澳大利亚与新西兰皇家精神科医师学会(RANZCP,Royal Australian and New Zealand college of Psychiatrists) · 2016-04-27

2016NICE：儿童和青少年精神病和精神分裂症:识别和管理指南更新

暂未更新 · 2016-06-12

2019 BAP循证指南：精神分裂症的药物治疗（更新版）

英国精神药理协会(BAP,British Association for Psychopharmacology) · 2019-12-12

精神分裂症患者代谢综合征管理的中国专家共识

中华医学会精神病学分会 · 2020-01-30

2020 APA实践指南：精神分裂症的治疗（第3版）

美国精神病学会(APA,American Psychiatric Association) · 2020-09-01